By: Jessica Jordan, A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used on breast cancer patients. That decision is clearing the way for the US government to remove its endorsement from the drug. Nearly a year ago a Food and Drug Administration Advisory Panel ruled that Avastin is ineffective, unsafe and should have its approval for breast cancer withdrawn. Joining us on the line to talk about this is Frank Burroughs, a spokesman for the group Abigail Alliance.Tags: Health, World, cancer, medicine, Commentary, Interview, Читать далее, Source: Voice of Russia.
